Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4795842
Max Phase: Preclinical
Molecular Formula: C60H75N15O9
Molecular Weight: 1150.36
Molecule Type: Unknown
Associated Items:
ID: ALA4795842
Max Phase: Preclinical
Molecular Formula: C60H75N15O9
Molecular Weight: 1150.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2cccc(-c3cccc4ccccc34)c2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O
Standard InChI: InChI=1S/C60H75N15O9/c1-3-4-21-46(69-35(2)76)54(79)75-51-31-52(77)65-25-10-9-23-45(53(61)78)70-57(82)49(29-39-32-67-44-22-8-7-19-43(39)44)73-55(80)47(24-13-26-66-60(62)63)71-56(81)48(72-58(83)50(74-59(51)84)30-40-33-64-34-68-40)28-36-14-11-17-38(27-36)42-20-12-16-37-15-5-6-18-41(37)42/h5-8,11-12,14-20,22,27,32-34,45-51,67H,3-4,9-10,13,21,23-26,28-31H2,1-2H3,(H2,61,78)(H,64,68)(H,65,77)(H,69,76)(H,70,82)(H,71,81)(H,72,83)(H,73,80)(H,74,84)(H,75,79)(H4,62,63,66)/t45-,46-,47-,48+,49-,50-,51-/m0/s1
Standard InChI Key: VPORMYBONMHESW-YJLRWSCOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1150.36 | Molecular Weight (Monoisotopic): 1149.5872 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Martin C,Gimenez LE,Williams SY,Jing Y,Wu Y,Hollanders C,Van der Poorten O,Gonzalez S,Van Holsbeeck K,Previti S,Lamouroux A,Zhao S,Tourwé D,Stevens RC,Cone RD,Ballet S. (2021) Structure-Based Design of Melanocortin 4 Receptor Ligands Based on the SHU-9119-hMC4R Cocrystal Structure†., 64 (1.0): [PMID:33190475] [10.1021/acs.jmedchem.0c01620] |
Source(1):